Successful administration of the first case in the clinical trial of MegaCalion's iPS platelets using our bioreactor!

The biotech venture company Megakaryon Corporation has successfully completed the first administration of a clinical trial in which platelets made from iPS cells were transfused to a patient. Our company is conducting joint research and development of a culture device that enables mass production of iPS platelets for the project being advanced by Megakaryon, achieving high-efficiency production using single-use bioreactors.
For more details, please see the news release in the related links.

Inquiry about this news
Contact Us OnlineMore Details & Registration
Details & Registration